CME Information
Title & Description:
ASNC2022 OnDemand is a digital library of 55.25 hours of educational content presented from the ASNC2022 27th Annual Scientific Meeting hosted September 8-25, 2022.
ASNC2022 OnDemand features:
- Online video access to presenters’ slides with synchronized audio
- Searchable slide content
- Ability to earn up to 55.25 AMA PRA Category 1 Credits™
- PC and MAC compatible
- Mobile version for most smartphone and tablet devices
- MP3 downloads
Overall Purpose: This activity will increase learners’ competence in solving technical and clinical issues when treating patients with CVD. Sessions present different approaches to cardiac disease management to how to best improve patient outcomes. These sessions address topics in appropriate use criteria, SPECT best practices, PET best practices, new and emergent cardiac imaging procedures, lab performance and procedures, radiation safety, reporting, and lab performance and the application of appropriate guidelines-based treatments.
Statement of Need
In order to maintain competence and improve performance, imaging professionals must assimilate and integrate knowledge spanning multiple areas, including clinical data, technical aspects of imaging, and appropriate application of imaging (e.g., clinical guidelines and appropriate use criteria). Each of these areas is constantly evolving, particularly as innovative technologies and novel pharmacologic agents are introduced. ASNC2022 On Demand is an educational activity designed to help imaging professionals on how to best improve outcomes for their patients with CVD.
Target Audience
This course is intended for cardiologists, radiologists, nuclear medicine specialists, practice administrators, nuclear technologists, nurses and other health care professionals with an interest in the field of nuclear cardiology.
Learning Objectives:
At the end of this activity, participants will:
- Demonstrate improved skills in image interpretation and reporting
- Learn how to recognize and minimize technical problems and artifacts that may be associated with cardiac imaging
- Learn the appropriate use of cardiac imaging techniques based on current guidelines
- Evaluate new imaging technologies, software, and stress techniques
- Understand the role of nuclear and cardiac CT imaging in overall patient care
- Learn the importance of balancing radiation exposure with image quality
- Describe future directions in cardiac PET, CT, and SPECT/CT in order to anticipate training and equipment needs
- Understand the clinical implication of CT coronary angiography cases and recognize its value and limitations in clinical cardiology
Important Dates
Date of Release: October 5, 2022
Date of CME Expiration: September 26, 2023
Date of Termination: September 26, 2024
Please note that credit will only be available through the term of approval noted above.
Accreditation and Continuing Education Credit
Physicians: The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Society of Nuclear Cardiology designates this internet enduring activity for a maximum of 55.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Policy
As an Accreditation Council for Continuing Medical Education (ACCME) accredited continuing medical education (CME) provider, the American Society of Nuclear Cardiology adheres to the ACCME’s Standards for Commercial Support. In compliance with these standards, it is ASNCs policy to ensure balance, independence, objectivity, and scientific merit in all of its educational activities through disclosure of relevant financial relationships with commercial companies and resolution of conflicts of interest. The financial interest or relationships requiring disclosure are outlined in ASNC’s Conflict of Interest Policy. All planners, reviewers, moderators, presenters involved in this activity were required to disclose all financial relationships. The American Society of Nuclear Cardiology has reviewed this activity’s faculty disclosures and managed or mitigated all identified conflicts of interests.
To receive CME credit for this product, you must:
- Purchase the product.
- Read the CME Information available when you first enter the player or by clicking the CME Info link in the top right corner.
- View the session(s) of your choosing.
- View a CME eligible session and select the “Take Test” button in blue beneath the session to evaluate and claim credit.
- You may generate and print your CME certificate at any time by selecting the middle button in the upper right of your OnDemand.
Planners
Program Chairs
Karthikeyan Ananthasubramaniam, MD, FASNC, Chair
Rami Doukky, MD, FASNC, Vice-chair
Program Committee
Brian Abbott, MD, MASNC
Niti Aggarwal, MD, FASNC
Mouaz Al-Mallah, MD, MSc, FASNC
Parthiban Arumugam, MB BS
Renee Bullock-Palmer, MD, FASNC
Manuel Cerqueira, MD, MASNC
Panithaya Chareonthaitawee, MD
Paul Cremer, MD
Robert deKemp, PhD, FASNC
Sharmila Dorbala, MD, MPH, MASNC
Timothy Dunn, CNMT
Andrew Einstein, MD, PhD, FASNC
Cesia Gallegos, MD
Wael Jaber, MD
Diwakar Jain, MD, MASNC
Frederike Keatinge, MD
Madison Kocher, MD
Haresh Majmundar, CNMT, RT(N)
Saurabh Malhotra, MD, MPH, FASNC
Heisha McCall, PhD
Edward Miller, MD, PhD, FASNC
Venkatesh Murthy, MD, PhD, FASNC
Krishna Patel, MD
Donna Polk, MD, MPH, FASNC
Terrence Ruddy, MD, MASNC
Raymond Russell, MD, PhD, MASNC
Mehran Sadeghi, MD
Ibrahim Saeed, MD
Rupa Sanghani, MD, FASNC
Thomas Schindler, MD
Ronald Schwartz, MD, MS, MASNC
Nishant Shah, MD, MPH, FASNC
Albert Sinusas, MD, FASNC
Piotr Slomka, PhD, FASNC
Prem Soman, MD, PhD, MASNC
Vikas Veeranna, MD
Disclosure Information Report
American Society of Nuclear Cardiology
Faculty/Planner Disclosures
The following individuals have stated that they have no financial relationships with any ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing products used by or own patients, including computer software/hardware, related to the content of the educational presentation in which they are involved:
Bryan Abadie, MD
Brian G. Abbott, MD, MASNC
Shady Abohashem, MD
Wael AlJaroudi, MD, FASNC
Erin Armenia, MD
Benjamin Auer, PhD
Sabha Bhatti, MD, FASNC
George A. Beller, MD, MASNC
Stephen A. Bloom, MD, FASNC
Renee Bullock-Palmer, MD, FASNC
Dennis A. Calnon, MD, MASNC
Paul Cremer, MD
Simhan Danthi, , PhD
- Gordon DePuey, MD, MASNC
Sanjay Divakaran, MD
Tifany Dong, MD
Eoin Donnellan, MB, BCh
Rami Doukky, MD, MBA, FASNC
Timothy L. Dunn, CNMT
Jane Dunne
Monica Embry-Dierson, CNMT
Mary Beth Farrell, CNMT, NCT
Mario Garcia, MD
Akshay Goel, MD
Javier Gomez Valencia, MD
Alan Goldberg, MD
Javier Gomez Valencia, MD
John P. Greenwood, MD
Robert C. Hendel, MD, MASNC
Milena J. Henzlova, MD, PhD, MASNC
Stephen Horgan, MD
Erika Hutt, MD
Ami E. Iskandrian, MD, MASNC
Anas Jawaid, MD
Abhinav Jha, PhD
Lynne L. Johnson, MD
Hayan Jouni, MD
Raghav Julakanti, MD
Friederike Keating, MD
Shaden Khalaf, MD
Madison Kocher, MD
Bruno Lima, MD, PhD
Maria L. Mackin, MS, CNMT, RT(N)
Chaitanya Madamanchi, MD
Samia Massalha, MD, FASNC
Keisha McCall, PhD
Matthew J. Memmott, MSc
Edward J. Miller, MD, PhD, FASNC
Faisal Nabi, MD
Diana Paez, MD
Shivda Pandey, MD
Gary Parizher, MD
Mi-Ae Park, PhD
Krishna Patel, MD
Donna M. Polk, MD, MPH, FASNC
Prajwal Reddy, MD
Dawn Roberts
Jeffrey A. Rosenblatt, MD, FASNC
Jean Michael Saad, MD
Thomas H. Schindler, MD, PhD
Eric J. Schockling, CNMT
Ronald G. Schwartz, MD MS, MASNC
Maria Sciammarella, MD
Ravi Shah, MD
Mrinali Shetty, MD
John Stendahl, MD, PhD
Amanda Swift, CNMT
Suman Tandon, MD
Viviany R. Taqueti, MD, FASNC
Samee Taywade, MB BS
Amr Telmasani, MB BS
Randall C. Thompson, MD, FASNC
Vikas Veeranna, MD
Brittany Weber, MD, PHD
Christiane Wiefels, MD, MSc
Kim A. Williams Sr., MD, MASNC
David E. Winchester, MD, FASNC
Kathleen Young, MD
George Zubal, PhD
The following individuals have provided financial relationships with ineligible company whose primary business is producing, marketing, selling, re-selling, or distributing products used by or own patients, including computer software/hardware, related to the content of the educational presentation in which they are involved:
Niti R. Aggarwal, MD, FASNC – Speaker/Honoraria: Elsevier
Cigdem Akincioglu, MD – Consultant and Speaker/Honoraria: Pfizer Canada
Mouaz H. Al-Mallah, MD, MSc, FASNC – Consultant: Phillips, Jubilant, Pfizer; Research Grant: Siemens
Karthikeyan Ananthasubramaniam, MD, FASNC – Research Grant: Astellas, Lantheus, Alnylam, BMS; Speaker/Honoraria: BMS (non-branded)
Ian S. Armstrong, PhD – Speaker/Honoraria: Siemens; Other: Departmental collaboration – Siemens
Parthiban Arumugam, MBBS – Speaker/Honoraria: IBA
Mir Basir, DO – Consultant: Abbott Vascular, Abiomed, Boston Scientific, Cardiovascular Systems, Zoll; Research Grant: Abiomed, Zoll; Speaker/Honoraria: Abiomed, Boston Scientific, Cardiovascular Systems, Zoll
Timothy M. Bateman, MD, MASNC – Consultant: GEHC; Research Grant: Bracco, GEHC, Spectrum Dynamics; Owner/Interest: SPECT and PET software products
Rob S.B Beanlands, MD, MASNC – Consultant: GEHC, Jubilant DRAXImage, Lantheus; Research Grant: GEHC, Siemens; Advisory Board: Pfizer, Abbott; Speaker/Honoraria: Curium, GEHC, Pfizer
Frank Bengel, MD – Research Grant: GEHC, Jubilant DRAXImage, Lantheus
Daniel S. Berman, MD, MASNC – Consultant: GEHC; Royalties: Cedars Sinai (software)
Ron Blankstein, MD, FASNC – Consultant: Amgen, Novartis, Silence Therapeutics, Caristo Inc., Star Therapeutics, Roivant Sciences; Research Grant: Amgen, Novartis
Sabahat Bokhari, MD – Advisory Board: Pfizer, Alnylam, Biobridge
Jamieson M. Bourque, MD, FASNC – Consultant: Pfizer, GEHC
Paco Bravo, MD – CARDIAG Steering Committee: Life Molecular Imaging; Research Grant: Lantheus, Pfizer, Novartis
James A. Case, PhD – Research Grant: GEHC, Bracco Diagnostics, DRAXImage; Owner/Interest: CVIT
Manuel D. Cerqueira, MD, MASNC – Consultant: GEHC; Speaker/Honoraria: Astellas
Panithaya Chareonthaitawee, MD – Consultant: BioClinica; Royalties: UpToDate
Leslie Cho, MD – Consultant: AstraZeneca
Andrew Choi, MD – Consultant: Siemens Healthineers; Other: Cleerly (stock)
Benjamin Chow, MD, FASNC – Research Grant: TD Bank, AusculSciences, Artyra, Siemens; Owner/Interest: Artrya (stock options)
Sarah Cuddy, MB ChB – Research Grant: Pfizer; Speaker/Honoraria: BridgeBio, Ionis, Lynx Group
Robert A. deKemp, PhD, FASNC – Consultant: Jubilant DRAXImage; Research Grant: Jubilant DRAXImage, Lantheus, Siemens; Royalties: INVIA, Jubilant DRAXImage
Marcelo Di Carli, MD, MASNC – Research Grant: Gilead Sciences, Spectrum Dynamics
Vasken Dilsizian, MD, MASNC – Research Grant: GEHC
Sharmila Dorbala, MD, MPH, MASNC – Research Grant: Pfizer, GEHC, Attralus; Advisory Board: Pfizer, GEHC, Janssen, Eidos; Speaker/Honoraria: Ionetix
- Lane Duvall, MD, FASNC – Consultant: GEHC; Research Grant: GEHC
Andrew J. Einstein, MD, PhD, FASNC – Consultant: W.L. Gore & Assoc.; Research Grant: W.L. Gore & Assoc., GEHC (grants from columbia)
John Friedman, MD – Royalties: Cedars-Sinai software
Brian Ghoshharja, MD – Consultant & Gtants: Siemens (to institution); Consultant: Philips
Sherita Golden, MD, MHS – Consultant: Medtronic, Abbott; Advisory Board: Medtronic, Abbott
Robert J. Gropler, MD, MASNC – Research Grant: GEHC
Gabriel B. Grossman, MD, PhD, FASNC – Consultant: Pfizer, Siemens; Speaker/Honoraria: Siemens
Fadi G. Hage, MD, MASNC – Other: GEHC (Site for clinical trial)
Saen Hayes, MD – Royalties: Cedars-Sinai software
Gary V. Heller, MD, PhD, MASNC – Consultant: MIS, Digirad; Advisory Board: GEHC
Fabien Hyafil, MD, PhD
Consultant: Naogen Pharma, Bracco Imaging; Speaker: Pfizer, GE Healthcare, Bracco Imaging; Advisory Board: Naogen Pharma, Bracco Imaging; Stock options: Naogen Pharma
Mark C. Hyun, CNMT, NCT, RT(N)(R), FASNC – Consultant: Astellas; Speaker/Honoraria: Astellas
Wael A. Jaber, MD – Consultant: Pfizer; Other: Edwards Life Sciences, Boston Scientific (Instritutional Corelab: no personal payment)
Diwakar Jain, MD, MASNC – Consultant: Astellas; Research Grant: CSL Behring (investigator); Speaker/Honoraria: Astellas, Pfizer; Other: GEHC (member of DSMB multicenter trial
Scott Jerome, DO, FASNC – Advisory Board (health information technology group): Pfizer
Nils Johnson, MD Consultant (Institutional): Boston Scientific, Abbott Vascular; Speaker (institutional) Boston Scientific, Abbott Vascular; Other (institutional support): DEFINE FLOW, Impella study, PPG Registrty, HeartSee (license)
Joel Karp, PhD – Research Grant: Siemens, Philips (PI agreement with U.Penn)
Jamshid Maddahi, MD, FASNC – Consultant: GEHC; Research Grant: GEHC
Haresh Majmundar, CNMT, RT(N) – Consultant: GLG Corp.
Saurabh Malhotra, MD, MPH, FASNC – Consultant: Astellas, Eidos; Speaker/Honoraria: Astellas, Pfizer
Ahmad Masri, MD – Consultant: BMS, Cytokinetics, Eidos, Tenaya, Attralus, Ionis; Research Grant: Pfizer, Ultronics, Ionis – Speaker/Honoraria: Alnylam, Pfizer
Venkatesh Murthy, MD, PhD, FASNC – Consultant: INVIA, Ionetix, Siemens; Research Support: NHLBI, NIA, NCI, INVIA, Siemens; Stock options: General Electric, Cardinal Health, Ionetix
Michael T. Osborne, MD – Consultant: WCG Intrinsic Imaging; Research Grant: NIH
Amit R. Patel, MD – Research Grant: Circle CVU, Siemens Healthineers, General Electric
Lawrence M. Phillips, MD, FASNC – Consultant: NovoNordisk: research study clinical ev adjudication committee
Terrence D. Ruddy, MD, MASNC – Research Grant: GEHC, Advanced Accelerator Applications; Speaker/Honoraria: Ion Beam Applications
Raymond R. Russell III, MD, PhD, MASNC – Speaker/Honoraria: Alnylam; Royalties: Dicerna Pharmaceuticals (stock options); Other: Restorbio, Disernca Pharma (spouse employer)
Mehran Sadeghi, MD – Consultant: Bracco; Resarch Materials” Alexion Pharmaceuticals; Other: Boehringer Ingelheim (spouse employment)
Rupa Mehta Sanghani, MD, FASNC – Advisory Board: FDA Medical Imaging; Other: Elsevier (writer)
Nishant Shah, MD, MPH, FASNC – Royalties: GEHC (stock)
Leslee J. Shaw, PhD, MASNC – Advisory Board: Covanos, Elucid Imaging; Speaker/Honoraria: Amgen, Roche Diagnostics, K2P
Chetan Shenoy, MD – Consultant: Medtronic
Vasvi Singh, MD – Research Grant: Pfizer
Albert J. Sinusas, MD, FASNC – Consultant: MicroVide, LLC (limited partner); Research Grant: Siemens, Jubilant
Piotr J. Slomka, PhD, FASNC – Research Grant: Siemens; Speaker/Honoraria: IBA; Royalties: Cedars_Sinai (software)
Prem Soman, MD, PhD, MASNC – Consultant: Alnylam, Spectrum Dynamics, Eidos, Pfizer; Research Grant: Pfizer, Astellas
Brett W. Sperry, MD – Consultant: Pfizer, BridgeBio, Alnylam; Speaker/Honoraria: Pfizer
Eric Velazquez, MD – Consultant: Novartis, Abiomed, Baim Inst. For Medical Research; Advisory Board: Novartis, Abiomed, Baim Inst. For Medical Research, Amgen
Jaime Warren, EdD,MBA, CNMT, NCT – Owner/Interest: MeAxiom (employee)
Richard Weinberg, MD, PhD, FASNC – Consultant: Ionetix
- Glenn Wells, PhD – Research Grant: Pfizer, GEHC
Jessica Williams, MS, RT(N), CNMT – Employee: Blue Earth Diagnostics, Ltd.
David G. Wolinsky, MD, MASNC – Consultant: Astellas, Pfizer, Alnylam, BridgeBio, Ionis – Advisory Board: Pfizer, Alnylam; Speaker/Honoraria: Astellas
Off Label-Use
Presentations may include discussion of drugs or devices, or uses of drugs or devices, which have not been approved by the U.S. Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. ASNC is committed to the free exchange of medical education. Inclusion of any discussion in this program, including discussion on off-label uses, does not imply an endorsement by ASNC of the uses, products or techniques presented. Presenters are required to disclose to the learners, if there is any off-label usage within the presentation.
Medium or Combination of Medium Used:
ASNC2022 OnDemand is available online on most mobile devices, including smartphones and tablets.
Hardware/Software Requirements: For the most current list of system requirements, please visit http://asnc.ondemand.org/.
Provider Contact Information:
For ASNC2022 OnDemand Customer Support:
[email protected] or (818) 844-3299; Toll Free (800) 501-2303 (U.S.A. only)
ASNC Contact Information:
American Society of Nuclear Cardiology
9302 Lee Highway, Suite 1210
Fairfax, Virginia 22031
Phone: 703-459-2555
[email protected]
Privacy Policy
This website is provided by Wolters Kluwer. By using this website, you consent to the use of your Personal Data as described in this Privacy Policy (‘Policy’). The Privacy Policy can be found at www.audio-digest.org/privacy and may be updated at any time.
Title & Description:
ASNC Nuclear Cardiology Board Exam Preparation Course OnDemand 2022 is a digital library of 31.25 hours of educational content presented at the 2022 September 17–18 Nuclear Cardiology Virtual Board Examination Prep Meeting, in addition to supplementary content from the ASNC2022 session, Nuclear Cardiology Foundations and Application: A Case-based Morning with the Board Prep Faculty.
Nuclear Cardiology Board Prep OnDemand features:
- Online access to presenters’ slides with synchronized audio
- Searchable slide content
- Ability to earn up to 31.25 AMA PRA Category 1 Credits™and 31.25 Maintenance of Certification (MOC) points
- MP3 downloads (‘podcasts’)
- PDF downloads of slide presentations
- PC and MAC compatible
- Mobile version for most smartphone and tablet devices
Overall Goal
The overall goal of this activity is to increase physician competence in nuclear cardiology by providing a comprehensive review, including the most up-to-date information, developments, treatment protocols, methodology, and best test for the right patient at the right time to optimize patient outcomes in their nuclear cardiology practice.
Needs Statement
Radionuclide-based cardiac imaging studies, including myocardial perfusion imaging (MPI), play an important role in the diagnosis and management of patients with suspected or known heart disease. Today more than 5000 laboratories are performing an estimated 8 million myocardial perfusion studies, of which 58% use pharmacological stress agents, either alone or with exercise.* A large body of scientific evidence exists on the clinical value of MPI, based on studies performed on many thousands of patients. These studies are highly sensitive and specific for the diagnosis, prognosis, and treatment response of coronary artery disease, as well as for selection of patients who may benefit from other types of intervention, including revascularization and device therapy. The value and justification of MPI for risk assessment is based on large observational outcome studies. As a result of the recognized clinical value and cost effectiveness of these studies, they have been incorporated into many ACC/American Heart Association (AHA)/ASNC clinical management guidelines.
Nuclear cardiology is an evolving field with continuing advances in software, instrumentation, and radiopharmaceuticals to provide high quality, clinically relevant information for patient care. These advances require those involved in providing nuclear cardiology studies to be updated continuously, to ensure the procedures are used appropriately and safely, and to assure recent clinical and technological advances are incorporated in a timely manner to continually improve the image quality and interpretation to provide the best clinical care.
*Dicardiology.com. IMV market report. Posted December 26, 2013.
Target Audience
This course is designed for cardiologists, nuclear medicine physicians, and radiologists preparing for the certification or recertification exam in nuclear cardiology.
Learning Objectives
The primary objectives of the course are to enable participants to achieve the following:
- Apply nuclear cardiovascular imaging physics and instrumentation
- Explain image acquisition and processing considerations and identify associated artifacts
- Discuss the production and management of radionuclides and radiopharmaceuticals
- Incorporate patient-centered imaging principles and appropriate use considerations in nuclear cardiology and stress procedure selection
- Incorporate risk stratification into selection and application of nuclear cardiology studies
- Integrate radiation safety standards into professional nuclear cardiology practice
- Apply nuclear imaging tools in assessment of myocardial viability and cardiac amyloidosis
- Understand the basics of positron emission tomography (PET) imaging for myocardial perfusion and metabolic viability and sarcoidosis assessment
- Interpret SPECT and PET perfusion and metabolic images and ventricular function imaging
- Utilize myocardial perfusion imaging in the assessment, diagnosis, and response to therapy in patients with known or suspected coronary artery disease and special populations
- Appropriately identify non-cardiac findings on SPECT and PET-CT cardiovascular imaging studies
- Integrate nuclear cardiology into the multimodality imaging evaluation of cardiovascular disease
Important Dates:
Date of Release: September 19, 2022
Date of CME Expiration: September 18, 2023
Date of Activity Expiration: September 18, 2024
Please note that credit will only be available through the term of approval noted above.
Accreditation Statement
Continuing Medical Education Credit
The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement
The American Society of Nuclear Cardiology designates this enduring material for a maximum of 31.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Requirements for successful completion and awarding of credit are as follows: participation in sessions offering credit in their entirety and successful completion of the post test and evaluation tool.
Maintenance of Certification
Successful completion of this CME activity, which includes participation in the CME post-test and evaluation component, enables the participant to earn up to 31.25 medical knowledge Maintenance of Certification (MOC) points in the American Board of Internal Medicine (ABIM) MOC program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.
To receive MOC points for participating in the Board Prep Course, you must be a diplomate of the American Board of Internal Medicine, and you must have an ABIM account. If you have not yet established an online account, you will need to visit http://www.abim.org, or contact ABIM by phone:
1-800-441-ABIM; Mon–Fri 8:30 am–8:00 pm ET, Sat 9:00 am–12:00 pm ET.
Please note, upon satisfactory completion of your Board Prep Course, passing the CME post-test, and completing the evaluation form, you will be prompted to enter your ABIM ID and DOB so your MOC points can be transferred to the ABIM. Please note this data will transfer at the end of every month into your ABIM record. ABIM will not accept MOC points for this internet live activity after September 18, 2023.
*Please Note: If you already claimed credit for attending the virtual live Nuclear Cardiology Board Exam Prep meeting, you may not claim credit for watching the same sessions on Nuclear Cardiology Board Prep OnDemand.
While offering the CME credits noted above, this program is not intended to provide extensive training or certification in the field.
Program Chairs & Faculty
Program Chair
Jamieson Bourque, MD, MHS, FASNC
University of Virginia Health System
Charlottesville, VA
Program Co-Chair
Karthikeyan Ananthasubramaniam, MD, FASNC
Henry Ford West Bloomfield Hospital
West Bloomfield, MI
James A. Case, PhD, MASNC
Cardiovascular Imaging Technologies, LLC
Kansas City, MO
Panithaya Chareonthaitawee, MD, FACC, FAHA
Mayo Clinic College of Medicine
Rochester, MN
- David Cooke, MSEE
Emory University School of Medicine
Atlanta, GA
- Gordon DePuey, MD, MASNC
Professor Emeritus of Radiology
Columbia University College of Physicians and Surgeons
Professorial Lecturer
Icahn School of Medicine
New York, NY
Marcelo F. Di Carli, MD, MASNC
Brigham and Women’s Hospital
Boston, MA
Nick Dorrell, MS, CHP
University of Virginia Health System
Charlottesville, VA
Wendy Galbraith, PharmD, FAPhA, BCNP
The University of Oklahoma Health Sciences Center
Department of Pharmaceutical Sciences
Oklahoma City, OK
Robert C. Hendel, MD, MASNC
Tulane University School of Medicine
New Orleans, LA
Andrew C. Homb, MD
Mayo Clinic College of Medicine
Rochester, MN
Mark C. Hyun, CNMT, NCT, RS, RT(N,R,CT), FASNC
Cedars-Sinai Medical Center
Los Angeles, CA
Saurabh Malhotra, MD, MPH, FACC, FASNC
Cook County Health
Chicago, IL
Ronald G. Schwartz, MD, MS, FACC, FAHA, ABNM, MASNC
University of Rochester Medical Center
Rochester, NY
Prem Soman, MD, PhD, MASNC, FACC, FRCP (UK)
UPMC Division of Cardiology & UPMC Heart and Vascular Institute
Pittsburgh, PA
Michael Welling
Radiation Safety Officer
University of Virginia Health System
Charlottesville, VA
David E. Winchester, MD, MS, FACP, FACC, FASNC
Malcom Randall VAMC
University of Florida College of Medicine
Gainesville, FL
Planners
Jamieson Bourque, MD, MHS, FASNC (Course Director and Chair)
Karthikeyan Ananthasubramaniam, MD, FASNC (Co-Chair)
Victoria Anderson (ASNC staff)
Wendy Passerell (ASNC staff)
Reviewer
Firas J. Al Badarin, MD, FASNC (Education Committee Oversight)
John Stendahl, MD, PhD (Education Committee Oversight)
Disclosures
As an accredited provider of the Accreditation Council for Continuing Medical Education (ACCME), The American Society of Nuclear Cardiology (ASNC) adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. In compliance with these standards, it is ASNC’s policy to ensure balance, independence, objectivity, and scientific merit in its educational activities through the disclosure of all financial relationship with ineligible companies and mitigation of conflicts of interest. The financial interest or relationships requiring disclosure are outlined in ASNC’s CME Conflict of Interest Policy. All planners, reviewers, and presenters involved with this activity were required to disclose all financial relationships. The American Society of Nuclear Cardiology has reviewed these disclosures and mitigated or managed all identified conflicts of interest through a peer review process.
The American Society of Nuclear Cardiology has reviewed this activity’s faculty disclosures and resolved or managed all identified conflicts of interest through a peer-review process.
The following planners, presenters, reviewers, and staff reported no financial relationships:
- Gordon DePuey, MD, MASNC
Nick Dorrell, MS, CHP
Wendy Galbraith, PharmD, FAPhA, BCNP
Andrew C. Homb, MD
Wendy Passerell (ASNC Staff)
Ronald G. Schwartz, MD, MS, FACC, FAHA, ABNM, MASNC
John Stendahl, MD, PhD
Michael Welling
David E. Winchester, MD, MS, FACP, FACC, FASNC
The following planners, presenters, reviewers, and staff reported financial relationships:
Firas J. Al Badarin, MD, FASNC: Advisory Board: Pfizer
Karthik Ananthasubramaniam, MD, FASNC: Research grants: Alnylam Pharmaceuticals, Astellas Pharma U.S. Inc., Bristol Myers Squibb, Lantheus Medical Imaging; Speakers Bureau: Bristol Myers Squibb.
Victoria Anderson (ASNC staff): Stock Interest, Abbott Labs and AbbVie Inc.
Jamieson Bourque, MD, MHS, FASNC: Consultant fee: Pfizer, GE Healthcare; Stock Interest: Locus Health
James A. Case, PhD, MASNC: Consultant fee: General Electric; Research grants: Bracco Diagnostics, General Electric, Jubilant DraxImage Inc., Siemens, Spectrum Dynamics; Intellectual Property Rights: Cardiovascular Imaging Technologies
Panithaya Chareonthaitawee, MD, FACC, FAHA: Consultant fee: Clario; Royalty: UpToDate®
- David Cooke, MSEE: Royalty: Syntermed, Inc. (Sales of Emory Cardiac Toolbox Software); Salaried Employee or Owner: Part-time employee of Syntermed, Inc.
Marcelo F. Di Carli, MD, MASNC: Institutional Research Grants: Gilead Sciences, Amgen; Funding from NHLBI
Robert Hendel, MD, MASNC: Speakers Bureau: Astellas Pharma
Mark C. Hyun, CNMT, NCT, RT(N)(R)(CT), FASNC: Consultant fee & Speakers Bureau: Astellas
Saurabh Malhotra, MD, MPH, FACC, FASNC: Advisory Board: Alnylam; Application Reviewer: Intersocietal Accreditation Commission (IAC); Research grants: Pfizer, Inc., Women’s Interagency HIV Study (WIHS); Speakers Bureau: Alnylam, Pfizer Inc.
Prem Soman, MD, PhD, MASNC, FACC, FRCP (UK): Consultant fees: Alnylam, Eidos, Spectrum Dynamics, Pfizer; Research Grant: Astellas Pharma, Pfizer
The American Society of Nuclear Cardiology reserves the right to modify faculty and topics as needed.
Off-Label Use
Presentations may include discussion of drugs or devices, or uses of drugs or devices, that have not been approved by the U.S. Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. ASNC is committed to the free exchange of medical education. Inclusion of any discussion in this program, including discussion on off-label uses, does not imply an endorsement by ASNC of the uses, products or techniques presented. Presenters are required to disclose to the learners, if there is any off-label usage within the presentation.
Acknowledgement of Commercial Support
This activity has not received any commercial support.
Method of Participation and CME Certificates
This product offers up to 31.25 AMA PRA Category 1 creditsTM and 31.25 ABIM Part II medical knowledge MOC points based on the number of hours you spend watching presentations and taking the post-test questions. You may re-enter the product as many times as you wish, but you can claim CME credit and MOC points only once.
To receive CME credit for this product, you must:
- Purchase the product.
- Read the CME Information available when you first enter the player or by clicking the CME Info link in the top right corner.
- View the session(s) of your choosing.
- After you have completed viewing all sessions for which you intend to claim credit, click the Test link in the top right corner to begin the post-test, which is required to claim credit.
- Complete the post-test. You must score 75% to earn credit. You have unlimited attempts to retake the post-test.
- Complete the meeting evaluation.
- Enter the number of credits you wish to claim (up to a maximum of 31.25 CME credits). Credits claimed should reflect the total number of hours you spent reviewing the CME information, watching sessions, and taking the post-test. (*If you already claimed credit for attending the virtual live Nuclear Cardiology Board Exam Prep Course, you may not claim credit for the same sessions on Nuclear Cardiology Board Prep OnDemand).
- Generate and print your CME certificate.
Estimated time for completion of activity is 31.25 hours.
Learner’s Bill of Rights
The American Society of Nuclear Cardiology (ASNC) recognizes that you are a life-long learner who has chosen to engage in continuing medical education to identify or fill a gap in knowledge, skill, or performance. As part of the ASNC’s duty to you as a learner, you have the right to expect that your continuing medical education experience with ASNC includes the following:
Content that:
- promotes improvements or quality in healthcare;
- is valid, reliable, and accurate;
- offers balanced presentations that are free of commercial bias for or against a product or service;
- is vetted through a process that resolves any conflicts of interests of planners, teachers, or authors;
- is driven and based on learning needs, not commercial interests;
- addresses the stated objectives or purpose; and
- is evaluated for its effectiveness in meeting the identified educational need.
A learning environment that:
- supports the learners’ ability to meet their individual needs;
- respects and attends to any special needs of the learners;
- respects the diversity of groups of learners; and
- is free of promotional, commercial, and/or sales activities.
Disclosure of:
- relevant financial relationships planners, teachers, and authors have with commercial interests related to the content of the activity; and
- commercial support (funding or in-kind resources) of the activity.
Participants are asked to evaluate the objectivity of each presentation and to identify any
perceived commercial bias.
Medium or Combination of Medium Used:
Nuclear Cardiology Board Prep OnDemand is available online on most mobile devices, including smartphones and tablets.
Hardware/Software Requirements: For the most current list of system requirements, please visit http://asnc.ondemand.org/.
Provider Contact Information:
For Nuclear Cardiology Board Prep OnDemand Customer Support:
[email protected] or (818) 844-3299; Toll Free (800) 501-2303 (U.S.A. only)
ASNC Contact Information:
American Society of Nuclear Cardiology
9302 Lee Highway, Suite 1210
Fairfax, Virginia 22031
Phone: 703-459-2555
[email protected]
Privacy Policy
This website is provided by Learner’s Digest International LLC. By using this website you consent to the use of your Personal Data (Defined Below) as described in this Privacy Policy (‘Policy’). The Privacy Policy can be found at www.audio-digest.org/privacy and may be updated at any time.
ASNC2023: 28th Annual Session Meeting on Demand
American Society of Nuclear Cardiology
Title & Description:
ASNC2023 OnDemand is a digital library of 25 hours of educational content presented from the ASNC2023 28th Annual Scientific Meeting hosted September 29 – October 7, 2023.
ASNC2023 OnDemand features:
- Online video access to presenters’ slides with synchronized audio
- Searchable slide content
- Ability to earn up to 25 AMA PRA Category 1 Credits™
- PC and MAC compatible
- Mobile version for most smartphone and tablet devices
- MP3 downloads
Overall Goal
This activity will increase learners’ competence in solving technical and clinical issues when treating patients with CVD. Sessions present different approaches to cardiac disease management to how to best improve patient outcomes. These sessions address topics in appropriate use criteria, SPECT best practices, PET best practices, new and emergent cardiac imaging procedures, lab performance and procedures, radiation safety, reporting, and lab performance and the application of appropriate guidelines-based treatments.
Statement of Need
To maintain competence and improve performance, imaging professionals must assimilate and integrate knowledge spanning multiple areas, including clinical data, technical aspects of imaging, and appropriate application of imaging (e.g., clinical guidelines and appropriate use criteria). Each of these areas is constantly evolving, particularly as innovative technologies and novel pharmacologic agents are introduced. ASNC2023 OnDemand is an educational activity designed to help imaging professionals on how to best improve outcomes for their patients with CVD.
Target Audience
This course is intended for cardiologists, radiologists, nuclear medicine specialists, nuclear technologists, nurses, practice administrators, and other health care professionals with an interest in the field of nuclear cardiology.
Learning Objectives:
At the end of this activity, participants will:
- Demonstrate improved skills in image interpretation and reporting
- Recognize and minimize technical problems and artifacts that may be associated with cardiac imaging
- Identify appropriate use of cardiac imaging techniques based on current guidelines
- Evaluate new imaging technologies, software, and stress techniques
- Identify the role of nuclear and cardiac CT imaging in overall patient care
- Describe the importance of balancing radiation exposure with image quality
- Describe future directions in cardiac PET, CT, and SPECT/CT to anticipate training and equipment needs
- Identify the clinical implication of CT coronary angiography cases and recognize its value and limitations in clinical cardiology
Important Dates
Date of Release: October 16, 2023
Date of CME Expiration: October 15, 2024
Date of Termination: October 15, 2025
Please note that credit will only be available through the term of approval noted above.
Accreditation and Continuing Education Credit
Physicians: The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Nuclear Cardiology designates this internet enduring activity for a maximum of 25* AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Policy
As an accredited provider of the Accreditation Council for Continuing Medical Education (ACCME), The American Society of Nuclear Cardiology (ASNC) adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. In compliance with these standards, it is ASNC’s policy to ensure balance, independence, objectivity, and scientific merit in all its educational activities through the disclosure of all financial relationship with ineligible companies and mitigation of conflicts of interest. The financial interest or relationships requiring disclosure are outlined in ASNC’s CME Conflict of Interest Policy. All planners, reviewers, and presenters involved with this activity were required to disclose all financial relationships. The American Society of Nuclear Cardiology has reviewed this activity’s faculty disclosures and mitigated all identified conflicts of interest.
To receive CME credit for this product, you must:
- Purchase the product.
- Read the CME Information available when you first enter the player or by clicking the CME Info link in the top right corner.
- View the session(s) of your choosing.
- View a CME eligible session and select the “Take Test” button in blue beneath the session to evaluate and claim credit.
- You may generate and print your CME certificate at any time by selecting the middle button in the upper right of your OnDemand.
PLANNERS
Program Chairs
Rami Doukky, MD, MSc, MBA, FASNC – Chair
Renée Bullock-Palmer, MD, FASNC – Vice-chair
Program Committee
Brian Abbott, MD, MASNC
Omar F. AbouEzzeddine, MD, MS
Niti Aggarwal, MD, FASNC
Fares Alahdab, MD, MSc
Rob S.B. Beanlands, MD, MASNC
Panithaya Chareonthaitawee, MD
Paul C. Cremer, MD, MS
Robert deKemp, PhD, MASNC
Sharmila, Dorbala, MD, MPH, MASNC
- Lane Duvall, MD, FASNC
Robert Hendel, MD, MASNC
Erika Hutt, MD
Wael Jaber, MD
Haresh Majmundar, CNMT, RT(N)
Saurabh Malhotra, MD, MPH, FASNC
Ahmad Masri, MD
Venkatesh Murthy, MD, PhD, FASNC
Krishna Patel, MD
Rupa Sanghani, MD, FASNC
Nishant Shah, MD, MPH, FASNC
Mrin Shetty, MD
Vasvi Singh, MD
Brett W. Sperry, MD
Erin Stevens, CNMT, NCT
Suman Tandon, MD, FASNC
Richard Weinberg, MD, PhD, FASNC
Disclosure Information Report
American Society of Nuclear Cardiology
FACULTY/PLANNER DISCLOSURES
The following individuals have stated that they have no financial relationships with any ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing products used by or own patients, including computer software/hardware, related to the content of the educational presentation in which they are involved:
Ahmed Aljizeeri, MBBS, FASNC
Ahmed Sami Abuzaid, MD
Alessia Gimelli, MD
Alfonso H. Waller, MD, FASNC
Attila Feher, MD, PhD
Christiane Wiefels, MD, MSc
David E. Winchester, MD, FASNC
David Konur, MHA, FACHE
Dennis A. Calnon, MD, MASNC
Donna M. Polk, MD, MPH, MASNC
Erika Hutt, MD
Erin Stevens, CNMT, NCT
Ernest G. DePuey, MD, MASNC
Faisal Nabi, MD
Fares Alahdab, MD, MSc
Firas Al Badarin, MD, FASNC
Friederike Keating, MD
Gary Parizher, MD
Gregory S. Thomas, MD, MPH, MASNC
Haresh Majmundar, CNMT, RT(N)
Ibrahim M. Saeed, MD
Jaime Warren, Ed.D, MBA, BHS, CNMT, NCT, FACC
Jeffrey A. Rosenblatt, MD, FASNC
Jennifer H. Mieres, MD, MASNC
Kim A. Williams, MD, MASNC
Krishnan Prabakaran, CNMT
Mahesh Vidula, M.D.
Maria G. Sciammarella, MD
Maria L. Mackin, MS, CNMT, RT(N), FASNC
Matthew E. Harinstein, MD, FASNC
Monica Malecki, CNMT, RT(N)(CT)
Mrinali Shetty, MD
Mylan C. Cohen, MD, MPH, MASNC
Niti R. Aggarwal, MD, FASNC
Odayme Quesada, MD
Paola A. Erba, MD, PhD
Parthiban Arumugam, MB BS
Patrick Miller, MD
Paul C. Cremer, MD, MS
Rami Abazid
Rami Doukky, MD, MSc, MBA, FASNC
Randall C. Thompson, MD, MASNC
Regina S. Druz, MD, FASNC
René R. Packard, MD, PhD
Renée Bullock-Palmer, MD, FASNC
Riemer H.J.A. Slart, MD
Robert C. Hendel, MD, MASNC
Robert J. Gropler, MD, MASNC
Ronald G. Schwartz, MD, MS, MASNC
Rupa Sanghani, MD, FASNC
Ryan Daly, MD
Sanjay Divakaran, MD
Stephen Bloom, MD, FASNC
Stephen Horgan, MD, PhD
Steven C. Port, MD
Suman Tandon, MD, FASNC
Tara Retson, MD, PhD
Tiffany Dong, MD
Timothy L. Dunn, CNMT
Vikas Veeranna, MD
Viviany R. Taqueti, MD, FASNC
Wael Aljaroudi, MD, FASNC
William A. Van Decker, MD, MASNC
The following individuals have provided financial relationships with ineligible company whose primary business is producing, marketing, selling, re-selling, or distributing products used by or own patients, including computer software/hardware, related to the content of the educational presentation in which they are involved:
Ahmad Masri, MD – Research/Grant or Contractor; Pfizer, Cytokinetics, Attralus, Ionis. Consulting Fee; Cytokinetics, BMS, Eidos, Pfizer, Ionis, Lexicon, Attralus, Haya,BioMarin and Tenaya.
Amit R. Patel, MD – Research/Grant or Contractor; GE Healthcare, CircleCVI, Neosoft, Siemens Healthineers. Speakers’ Bureau; GE Healthcare.
Benjamin Chow, MD, FASNC – Research/Grant or Contractor; TD Bank, Artrya, Siemens. Consulting Fee; Artrya. *Stock Interest (stocks, stock options or other ownership interest, excluding diversified mutual funds); Artrya.
Brett W. Sperry, MD – Speakers’ Bureau; Pfizer. Advisory Board; Alnylam, BridgeBio.
Brian G. Abbott, MD, MASNC – Stock Investment, Accumed Radial Systems, LLC
Brittany Weber, MD, PhD – Speakers’ Bureau; Kinisika.
Charles David Cooke, MSEE – *Stock Interest (stocks, stock options or other ownership interest, excluding diversified mutual funds); Syntermed, Inc.. *Salaried Employee or Owner; Syntermed, Inc.. Royalty; Emory Cardiac Toolbox.
Cigdem Akincioglu, MD, FRCPC, FEBNM – Research/Grant or Contractor; Pfizer Canada. Honoraria; Canadian Association of Nuclear Medicine.
Daniel S. Berman MD, MASNC – Research/Grant or Contractor; GE Healthcare. Royalty; software royalties.
David G. Wolinsky, MD, MASNC – Speaker Consultant: Astellas; Consultant Advisory Board: Pfizer Inc., Alnylam; Consultant: Bridg Bio, Ionis
Ed Nicol, MD, MBA – Consulting Fee; Medneo Ltd. Advisory Board; Caristo Diagnostics.
Edward J. Miller, MD, PhD, FASNC – Research/Grant or Contractor; Alnylam, Pfizer. Consulting Fee; Pfizer. Advisory Board; GE, CSL Behring.
Fabien Hyafil, MD, PhD – Consulting Fee: Blue Earth Diagnostics,Curium Pharma, GE Healthcare, Naogen Pharma; Advisory Board: Naogen Pharma; Stock Interest: Naogen Pharma
Fadi G. Hage, MD, MASNC – Research/Grant or Contractor; GE Healthcare, site PI on clinical trial, AstraZeneca, site PI on clinical trial, Idorsia, site PI on clinical trial.
Fernando Mendoza, MD – Speakers’ Bureau; Pfizer.
Gabriel B. Grossman, MD, PhD, FASNC – Speakers’ Bureau; Pfizer. Honoraria; Pfizer.
Gary R. Small, MBChB, PhD MRCP – Research/Grant or Contractor; Pfizer.
Gary V. Heller, MD, PhD, MASNC – Consulting Fee; Molecular Imaging Services. Royalty; McGrawHill Publishing. Advisory Board; GE Healthcare.
Ian S. Armstrong, PhD – Honoraria; Siemens.
- Dawn Abbott, MD – Research/Grant or Contractor; Microport (institutional), Boston Scientific (institutional), Med Alliance (institutional), Shockwave ( institutional). Consulting Fee; Penumbra, Rapid AI, Abbott. Royalty; Uptodate. Advisory Board; Medtronic.
James A. Case, PhD, MASNC – Research/Grant or Contractor; Bracco. *Stock Interest (stocks, stock options or other ownership interest, excluding diversified mutual funds); CVIT. Intellectual property rights; CVIT.
James E. Udelson, MD, MASNC – Research/Grant or Contractor; Medtrace. Consulting Fee; Medtrace, GE Healthcare.
Jamieson M. Bourque, MD, FASNC – Advisory Board; GE Healthcare.
Janet Wei, MD – Advisory Board; Abbott Vascular.
Jennifer Renaud, MSc – Consulting Fee; Jubilant Radiopharma. *Salaried Employee or Owner; INVIA Medical Imaging Solutions. Royalty; FlowQuant software.
Jignesh K. Patel, MD PhD – Research/Grant or Contractor; Alnylam, Ionis, Bridgebio, NovoNordisk.
Joanna E. Kusmirek, MD – Consulting Fee; Bayer.
John D. Friedman, MD – Intellectual property rights; Royalty payments for Cedars-Sinai Cardiac imaging reporting software.
Karen Ordovas, MD, MS, FSCMR, FAHA, FNASCI – Research/Grant or Contractor; American College of Radiology.
Karthikeyan Ananthasubramaniam, MD, FASNC – Research/Grant or Contractor; Ionis Pharmaceuticals, Bristol Myers Squibb, Myokardia, Alnylam Pharmaceuticals, Astellas Pharma. Speakers’ Bureau; Bristol Myers Squibb ( non branded ).
Kate Hanneman, MD, MPH, FRCPC – Honoraria; Sanofi.
Katherine A. Zukotynski, MD, PhD – Consulting Fee; Invicro, GE, Imaging Endpoint, Fusion. Speakers’ Bureau; AAA.
Khaled Ziada, MD – Research/Grant or Contractor; Genetesis. Speakers’ Bureau; Abbott Vascular, Inc.
Krishna K. Patel, MD, MSc – Research/Grant or Contractor; Jubilant DraxImage.
Lane Duvall, MD, FASNC – Research/Grant or Contractor; GE HealthCare.
Lawrence Phillips, MD, FASNC – Consulting Fee; Novo Nordisk.
Marcelo F. Di Carli, MD, MASNC – Research/Grant or Contractor; Gilead Sciences. Consulting Fee; Sanofi, MedTrace. Other financial benefit In-kind research support from Amgen.
Mark C. Hyun, CNMT, NCT, RT(N,R,CT), RS, FASNC – Consulting Fee; Astellas. Speakers’ Bureau; Astellas.
Mary Norine Walsh, MD – Research/Grant or Contractor; EBR Systems, Cardionomics. Advisory Board; Regeneron.
Matthieu Pelletier-Galarneau, MD, MSc, FRCPC – Research/Grant or Contractor; Jubilant Radiopharma. Speakers’ Bureau; Jubilant Radiopharma.
Mouaz H. Al-Mallah, MD, MSc, FASNC – Research/Grant or Contractor; Siemens. Consulting Fee; Pfizer, Jubilant.
Nils P. Johnson, MD, MS – Research/Grant or Contractor; CoreAalst (PPG registry, NCT04789317), Abiomed (local study of Impella-related coronary physiology), Neovasc (COSIRA-2, NCT05102019). Speakers’ Bureau; frequently invited by academia and industry to speak at educational meetings/conferences on hemodynamic physiology or cardiac PET and receive travel expenses. Royalty; University of Texas licenses HeartSee for cardiac PET (FDA 510(k) K113754, K143664, K171303, K202679) but I receive no direct or indirect royalties. Intellectual property rights; pending patent on diagnostic methods for quantifying aortic stenosis and TAVI physiology (research license granted to OpSens), pending patent on algorithms to correct pressure tracings from fluid-filled catheters. Honoraria; any honorarium from industry or academia is donated to UT.
Nishant Shah, MD, MPH, FASNC – Research/Grant or Contractor; Pfizer, Inc.. Honoraria; Pfizer, Inc.
Olivier F. Clerc, MD, MPH – Research/Grant or Contractor; Research fellowship from the International Society of Amyloidosis and Pfizer.
Omar F. AbouEzzeddine, MD, MS – Research/Grant or Contractor: Pfizer Inc.
Panithaya Chareonthaitawee, MD – Consulting Fee; Ionetix, Clario. Other financial benefit UpToDate.
Paul Friedman, MD – Other financial benefit A number of AI ECG algorithms have been licensed by Mayo Clinic to Anumana, Eko health, and AliveCor, and Mayo Clinic and Dr. Friedman may benefit financially from their commercialization.
Piotr J. Slomka, PhD, MASNC – Research/Grant or Contractor; Siemens Medical Systems. Consulting Fee; Synektik, SA. Royalty; Cedars-Sinai.
Prem Soman, MD, PhD, MASNC – Research/Grant or Contractor; Pfizer. Advisory Board; Spectrum Dynamics, Eidos.
Raynold Ho, MS, MBA, CNMT, RT(N) – Royalty; ARRT, NM Exam Committee. Advisory Board; SNMMI Local Chapter.
Richard Weinberg, MD, PhD, FASNC – Consultant, Ionetix
Rob S.B. Beanlands, MD, MASNC – Research/Grant or Contractor; JDI, Lantheus, GEHC, MEdtrace. Consulting Fee; JDI. Advisory Board; GEHC.
Robert A. deKemp, PhD, MASNC – Consultant, research funding, patent license revenues, Jubilant Radiopharma (DraxImage); Software License Revenues, INVIA Medical Solutions; Research Funding, Lantheus Medical Imaging, Siemens Medical Solutions.
Robert Miller, MD – Research/Grant or Contractor; Pfizer.
Ron Blankstein, MD, FASNC – Research/Grant or Contractor; Beren PBC, Amgen Inc, Novartis Inc. Consulting Fee; Amgen Inc, Novartis Inc, Caristo Inc, Heartflow Inc, Elucid Inc.
Sabahat Bokhari, MD, FASNC – Speakers’ Bureau; Astellas, Pfizer, Alnylam. Advisory Board; Pfizer, Alnylam, Bridgebio.
Sanjog Kalra, MD, MSc, FSCAI – Research/Grant or Contractor; Medtronic. Consulting Fee; Abiomed, Boston Scientific, Medtronic, Avinger, Philips, Translumina, Cardiovascular Systems, Teleflex. Speakers’ Bureau; Abiomed, Boston Scientific, Medtronic, Avinger, Philips, Translumina, Cardiovascular Systems, Teleflex. Honoraria; Abiomed, Boston Scientific, Medtronic, Avinger, Philips, Translumina, Cardiovascular Systems, Teleflex
Sarah Cuddy, MD – Research Grant: Pfizer; Speaker Honorarium: BridgeBio, Ionis, The Lynx Group
Saurabh Malhotra, MD, MPH, FASNC – Speakers’ Bureau, Pfizer Inc.; Speakers’ Bureau and Consultant, Alnylam; Consultant, Eidos
Sharmila Dorbala, MD, MPH, MASNC – Research/Grant or Contractor; Pfizer, Attralus, GE healthcare, Phillips, Siemens. Consulting Fee; Novo Nordisk, Astra Zeneca
Susanna Mak, MD, PhD – Research/Grant or Contractor; Astra Zeneca. Speakers’ Bureau; Boeringher Ingelheim.
Terrence D. Ruddy, MD, MASNC – Research/Grant or Contractor; GE Healthcare.
Timothy M. Bateman, MD, MASNC – Research/Grant or Contractor; Bracco, GEHC, SpectrumDynamics. *Salaried Employee or Owner; CVIT – software only. Intellectual property rights; Imagen SPECT and PET software products. Advisory Board; GEHC, Synektik.
Vasvi Singh, MD – Research/Grant: ASNC and Pfizer Inc.; Speaker Bureau: Pfizer Inc.
Venkatesh L. Murthy, MD, PhD, FASNC – Research/Grant or Contractor; Siemens. Consulting Fee; INVIA, Siemens, Ionetix. *Stock Interest (stocks, stock options or other ownership interest, excluding diversified mutual funds); General Electric, Cardinal Health, Ionetix. Advisory Board; Ionetix.
Wael A. Jaber, MD FACC, FESC – Consulting Fee; boston scientific, BridgeBio.
Off Label-Use
Presentations may include discussion of drugs or devices, or uses of drugs or devices, which have not been approved by the U.S. Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. ASNC is committed to the free exchange of medical education. Inclusion of any discussion in this program, including discussion on off-label uses, does not imply an endorsement by ASNC of the uses, products or techniques presented. Presenters are required to disclose to the learners if there is any off-label usage within the presentation.
Medium or Combination of Medium Used:
ASNC2023 OnDemand is available online on most mobile devices, including smartphones and tablets.
Hardware/Software Requirements: For the most current list of system requirements, please visit http://asnc.ondemand.org/.
Provider Contact Information:
For ASNC2023 OnDemand Customer Support:
[email protected] or (818) 844-3299; Toll Free (800) 501-2303 (U.S.A. only)
ASNC Contact Information:
American Society of Nuclear Cardiology
9302 Lee Highway, Suite 1210
Fairfax, Virginia 22031
Phone: 703-459-2555
[email protected]
Privacy Policy
This website is provided by Wolters Kluwer. By using this website, you consent to the use of your Personal Data as described in this Privacy Policy (‘Policy’). The Privacy Policy can be found at www.audio-digest.org/privacy and may be updated at any time.
Nuclear Cardiology Board Prep OnDemand 2023
October 25, 2023–October 24, 2025
Note: CME credits must be claimed by October 24, 2024.
Title & Description:
ASNC Nuclear Cardiology Board Exam Preparation Course OnDemand 2023 is a digital library of 30.0 hours of educational content presented at the 2023 October 14–15 Nuclear Cardiology Virtual Board Examination Prep Meeting, in addition to supplementary content from the ASNC2022 session, Nuclear Cardiology Foundations and Application: A Case-based Morning with the Board Prep Faculty.
Nuclear Cardiology Board Prep OnDemand features:
- Online access to presenters’ slides with synchronized audio
- Searchable slide content
- Ability to earn up to 30.0 AMA PRA Category 1 Credits™and 30.0 Maintenance of Certification (MOC) points
- MP3 downloads (‘podcasts’)
- PDF downloads of slide presentations
- PC and MAC compatible
- Mobile version for most smartphone and tablet devices
Overall Goal
The overall goal of this activity is to increase physician competence in nuclear cardiology by providing a comprehensive review, including the most up-to-date information, developments, treatment protocols, methodology, and best test for the right patient at the right time to optimize patient outcomes in their nuclear cardiology practice.
Needs Statement
Radionuclide-based cardiac imaging studies, including myocardial perfusion imaging (MPI), play an important role in the diagnosis and management of patients with suspected or known heart disease. Today more than 5000 laboratories are performing an estimated 8 million myocardial perfusion studies, of which 58% use pharmacological stress agents, either alone or with exercise.* A large body of scientific evidence exists on the clinical value of MPI, based on studies performed on many thousands of patients. These studies are highly sensitive and specific for the diagnosis, prognosis, and treatment response of coronary artery disease, as well as for selection of patients who may benefit from other types of intervention, including revascularization and device therapy. The value and justification of MPI for risk assessment is based on large observational outcome studies. As a result of the recognized clinical value and cost effectiveness of these studies, they have been incorporated into many ACC/American Heart Association (AHA)/ASNC clinical management guidelines.
Nuclear cardiology is an evolving field with continuing advances in software, instrumentation, and radiopharmaceuticals to provide high quality, clinically relevant information for patient care. These advances require those involved in providing nuclear cardiology studies to be updated continuously, to ensure the procedures are used appropriately and safely, and to assure recent clinical and technological advances are incorporated in a timely manner to continually improve the image quality and interpretation to provide the best clinical care.
*Dicardiology.com. IMV market report. Posted December 26, 2013.
Target Audience
This course is designed for cardiologists, nuclear medicine physicians, and radiologists preparing for the certification or recertification exam in nuclear cardiology.
Learning Objectives
The primary objectives of the course are to enable participants to achieve the following:
- Apply nuclear cardiovascular imaging physics and instrumentation
- Explain image acquisition and processing considerations and identify associated artifacts
- Discuss the production and management of radionuclides and radiopharmaceuticals
- Incorporate patient-centered imaging principles and appropriate use considerations in nuclear cardiology and stress procedure selection
- Incorporate risk stratification into selection and application of nuclear cardiology studies
- Integrate radiation safety standards into professional nuclear cardiology practice
- Apply nuclear imaging tools in assessment of myocardial viability and cardiac amyloidosis
- Understand the basics of positron emission tomography (PET) imaging for myocardial perfusion and metabolic viability and sarcoidosis assessment
- Interpret SPECT and PET perfusion and metabolic images and ventricular function imaging
- Utilize myocardial perfusion imaging in the assessment, diagnosis, and response to therapy in patients with known or suspected coronary artery disease and special populations
- Appropriately identify non-cardiac findings on SPECT and PET-CT cardiovascular imaging studies
- Integrate nuclear cardiology into the multimodality imaging evaluation of cardiovascular disease
Important Dates:
Date of Release: October 25, 2023
Date of CME Expiration: October 24, 2024
Date of Activity Expiration: October 24, 2025
Please note that credit will only be available through the term of approval noted above.
Accreditation Statement
Continuing Medical Education Credit
The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement
The American Society of Nuclear Cardiology designates this enduring material for a maximum of 30.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Requirements for successful completion and awarding of credit are as follows: participation in sessions offering credit in their entirety and successful completion of the post test and evaluation tool.
Maintenance of Certification
Successful completion of this CME activity, which includes participation in the CME post-test and evaluation component, enables the participant to earn up to 30.0 medical knowledge Maintenance of Certification (MOC) points in the American Board of Internal Medicine (ABIM) MOC program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.
To receive MOC points for participating in the Board Prep Course, you must be a diplomate of the American Board of Internal Medicine, and you must have an ABIM account. If you have not yet established an online account, you will need to visit http://www.abim.org, or contact ABIM by phone:
1-800-441-ABIM; Mon–Fri 8:30 am–8:00 pm ET, Sat 9:00 am–12:00 pm ET.
Please note, upon satisfactory completion of your Board Prep Course, passing the CME post-test, and completing the evaluation form, you will be prompted to enter your ABIM ID and date of birth (month/day) for your MOC points to be transferred to the ABIM. ABIM will not accept MOC points for this internet live activity after October 24, 2025.
Please Note: If you already claimed credit for attending the Virtual Live Nuclear Cardiology Board Exam Prep meeting, you may not claim credit for the same sessions on Nuclear Cardiology Board Prep OnDemand.
While offering the CME credits noted above, this program is not intended to provide extensive training or certification in the field.
Program Chairs & Faculty
Program Chair
Jamieson Bourque, MD, MHS, FASNC
University of Virginia Health System
Charlottesville, VA
Program Co-Chair
Karthikeyan Ananthasubramaniam, MD, FASNC
Henry Ford West Bloomfield Hospital
West Bloomfield, MI
James A. Case, PhD, MASNC
Cardiovascular Imaging Technologies, LLC
Kansas City, MO
Panithaya Chareonthaitawee, MD, FACC, FAHA
Mayo Clinic College of Medicine
Rochester, MN
- David Cooke, MSEE
Atlanta, GA
- Gordon DePuey, MD, MASNC
Bay Ridge Medical Imaging
Brooklyn, NY
Columbia University College of Physicians and Surgeons
Professor Emeritus
New York, NY
Marcelo F. Di Carli, MD, MASNC
Brigham and Women’s Hospital
Boston, MA
Nick Dorrell, MS, CHP
University of Virginia Health System
Charlottesville, VA
Rami Doukky, MD, MSc, MBA, FASNC
Cook County Health
Chicago, IL
Wendy Galbraith, PharmD, FAPhA, BCNP
The University of Oklahoma Health Sciences Center
Department of Pharmaceutical Sciences
Oklahoma City, OK
Andrew C. Homb, MD
Mayo Clinic College of Medicine
Rochester, MN
Mark C. Hyun, CNMT, NCT, RS, RT(N,R,CT), FASNC
Cedars-Sinai Medical Center
Los Angeles, CA
Saurabh Malhotra, MD, MPH, FACC, FASNC
Cook County Health
Chicago, IL
Ronald G. Schwartz, MD, MS, FACC, FAHA, ABNM, MASNC
University of Rochester Medical Center
Rochester, NY
Prem Soman, MD, PhD, MASNC, FACC, FRCP (UK)
UPMC Division of Cardiology & UPMC Heart and Vascular Institute
Pittsburgh, PA
David E. Winchester, MD, MS, FACP, FACC, FASNC
Malcom Randall VAMC
University of Florida College of Medicine
Gainesville, FL
Planners
Jamieson Bourque, MD, MHS, FASNC (Course Director and Chair)
Karthikeyan Ananthasubramaniam, MD, FASNC (Co-Chair)
Victoria Anderson (ASNC staff)
Wendy Passerell (ASNC staff)
Reviewers
Firas J. Al Badarin, MD, FASNC (Education Committee Oversight)
Mrinali Shetty, MD (Education Committee Oversight)
Disclosures
As an accredited provider of the Accreditation Council for Continuing Medical Education (ACCME), The American Society of Nuclear Cardiology (ASNC) adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. In compliance with these standards, it is ASNC’s policy to ensure balance, independence, objectivity, and scientific merit in its educational activities through the disclosure of all financial relationship with ineligible companies and mitigation of conflicts of interest. The financial interest or relationships requiring disclosure are outlined in ASNC’s CME Conflict of Interest Policy. All planners, reviewers, and presenters involved with this activity were required to disclose all financial relationships. The American Society of Nuclear Cardiology has reviewed these disclosures and mitigated or managed all identified conflicts of interest through a peer review process.
The American Society of Nuclear Cardiology has reviewed this activity’s faculty disclosures and resolved or managed all identified conflicts of interest through a peer-review process.
The following planners, presenters, reviewers, and staff reported no financial relationships:
- Gordon DePuey, MD, MASNC
Nick Dorrell, MS, CHP
Rami Doukky, MD, MSc, MBA, FASNC
Andrew C. Homb, MD
Mark C. Hyun, CNMT, NCT, RT(N)(R)(CT), FASNC
Wendy Passerell (ASNC staff)
Ronald G. Schwartz, MD, MS, FACC, FAHA, ABNM, MASNC
Mrinali Shetty, MD (CME Reviewer)
David E. Winchester, MD, MS, FACP, FACC, FASNC
The following planners, presenters, reviewers, and staff reported financial relationships:
Firas J. Al Badarin, MD, FASNC (CME Reviewer): Advisory Board: Pfizer
Karthik Ananthasubramaniam, MD, FASNC: Advisory Board: Alnylam Pharmaceuticals; Research grants: Astellas Pharma U.S. Inc., Bristol Myers Squibb, Ionis Pharmaceuticals; Speakers Bureau: Bristol Myers Squibb
Victoria Anderson (ASNC staff): Stock Interest: Abbott, AbbVie Inc.
Jamieson Bourque, MD, MHS, FASNC: Advisory Board: GE Healthcare
James A. Case, PhD, MASNC: Consultant fee: General Electric; Research Grants: Bracco Diagnostics, General Electric, Jubilant DraxImage Inc., Siemens, Spectrum Dynamics; Intellectual Property Rights: Cardiovascular Imaging Technologies; Salaried Employee or Owner: Cardiovascular Imaging Technologies
Panithaya Chareonthaitawee, MD, FACC, FAHA: Consultant fee: Clario, Ionetix; Royalties: UpToDate®
- David Cooke, MSEE: Royalty: Syntermed, Inc. (Sales of Emory Cardiac Toolbox Software); Salaried Employee or Owner: Part-time employee of Syntermed, Inc.
Marcelo F. Di Carli, MD, MASNC: Consultant fee: MedTrace, Sanofi; Institutional Research Grants: Amgen, Gilead Sciences
Wendy Galbraith, PharmD, FAPhA, BCNP: Consultant fee: UPPI (United Pharmacy Partners), LLC
Saurabh Malhotra, MD, MPH, FACC, FASNC: Consultant fees: Alnylam, Eidos; Speakers Bureau: Alnylam, Pfizer Inc.
Prem Soman, MD, PhD, MASNC, FACC, FRCP (UK): Consultant fees: Alnylam, Spectrum Dynamics, Eidos, Pfizer; Research Grants: Astellas Pharma, Pfizer Inc.
The American Society of Nuclear Cardiology reserves the right to modify faculty and topics as needed.
Off-Label Use
Presentations may include discussion of drugs or devices, or uses of drugs or devices, that have not been approved by the U.S. Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. ASNC is committed to the free exchange of medical education. Inclusion of any discussion in this program, including discussion on off-label uses, does not imply an endorsement by ASNC of the uses, products or techniques presented. Presenters are required to disclose to the learners, if there is any off-label usage within the presentation.
Acknowledgement of Commercial Support
This activity has not received any commercial support.
Method of Participation and CME Certificates
This product offers up to 30.0 AMA PRA Category 1 creditsTM and 30.0 ABIM Part II medical knowledge MOC points based on the number of hours you spend watching presentations and taking the post-test questions. You may re-enter the product as many times as you wish, but you may claim CME credit and MOC points only once.
To receive CME credit for this product, you must:
- Purchase the product.
- Read the CME Information available on the OnDemand platform when you first enter the player or by clicking the CME Info link in the top right corner.
- View the session(s) of your choosing.
- After you have completed viewing all sessions for which you intend to claim credit, click the Test link in the top right corner to begin the post-test, which is required to claim credit.
- Complete the post-test. You must score 75% to earn credit. You have unlimited attempts to retake the post-test.
- Complete the meeting evaluation.
- Enter the number of credits you wish to claim (up to a maximum of 30.0 CME credits). Credits claimed should reflect the total number of hours you spent reviewing the CME information, watching sessions, and taking the post-test. (If you already claimed credit for attending the virtual live Nuclear Cardiology Board Exam Prep Course, you may not claim credit for the same sessions on Nuclear Cardiology Board Prep OnDemand).
- Generate and print your CME certificate.
Estimated time for completion of activity is 30.0 hours.
Learner’s Bill of Rights
The American Society of Nuclear Cardiology (ASNC) recognizes that you are a life-long learner who has chosen to engage in continuing medical education to identify or fill a gap in knowledge, skill, or performance. As part of the ASNC’s duty to you as a learner, you have the right to expect that your continuing medical education experience with ASNC includes the following:
Content that:
- promotes improvements or quality in healthcare;
- is valid, reliable, and accurate;
- offers balanced presentations that are free of commercial bias for or against a product or service;
- is vetted through a process that resolves any conflicts of interests of planners, teachers, or authors;
- is driven and based on learning needs, not commercial interests;
- addresses the stated objectives or purpose; and
- is evaluated for its effectiveness in meeting the identified educational need.
A learning environment that:
- supports the learners’ ability to meet their individual needs;
- respects and attends to any special needs of the learners;
- respects the diversity of groups of learners; and
- is free of promotional, commercial, and/or sales activities.
Disclosure of:
- relevant financial relationships planners, teachers, and authors have with commercial interests related to the content of the activity; and
- commercial support (funding or in-kind resources) of the activity.
Participants are asked to evaluate the objectivity of each presentation and to identify any
perceived commercial bias.
Medium or Combination of Medium Used:
Nuclear Cardiology Board Prep OnDemand is available online on most mobile devices, including smartphones and tablets.
Hardware/Software Requirements: For the most current list of system requirements, please visit http://asnc.ondemand.org/.
Provider Contact Information:
For Nuclear Cardiology Board Prep OnDemand Customer Support:
[email protected] or (818) 844-3299; Toll Free (800) 501-2303 (U.S.A. only)
ASNC Contact Information:
American Society of Nuclear Cardiology
9302 Lee Highway, Suite 1210
Fairfax, Virginia 22031
Phone: 703-459-2555
[email protected]
Privacy Policy
This website is provided by Learner’s Digest International LLC. By using this website, you consent to the use of your Personal Data (Defined Below) as described in this Privacy Policy (‘Policy’). The Privacy Policy can be found at www.audio-digest.org/privacy and may be updated at any time.
Sync Across All Devices
Earn Credits with Online Testing
Download PDFs and MP3 Files
ASNC Nuclear Cardiology Board Prep OnDemand
Add Your Heading Text Here
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.